Sage Therapeutics, Inc. (SAGE) News

Sage Therapeutics, Inc. (SAGE): $50.23

1.08 (+2.20%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add SAGE to Watchlist
Sign Up

Industry: Biotech


Ranked

of 373

in industry

Filter SAGE News Items

SAGE News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

SAGE News Highlights

  • For SAGE, its 30 day story count is now at 7.
  • Over the past 23 days, the trend for SAGE's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
  • The most mentioned tickers in articles about SAGE are BEAT, HUGE and UTHR.

Latest SAGE News From Around the Web

Below are the latest news stories about SAGE THERAPEUTICS INC that investors may wish to consider to help them evaluate SAGE as an investment opportunity.

Elizabeth Barrett At Sage Therapeutics Tops Up Holding By US$51k \

Even if it's not a huge purchase, we think it was good to see that Elizabeth Barrett, a Sage Therapeutics, Inc...

Yahoo | May 18, 2023

Sage Therapeutics to Present at Upcoming May Investor Conferences

CAMBRIDGE, Mass., May 03, 2023--Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that the Company will present at the following upcoming investor conferences in May:

Yahoo | May 3, 2023

Sage Therapeutics, Inc. (SAGE) Reports Q1 Loss, Tops Revenue Estimates

Sage Therapeutics, Inc. (SAGE) delivered earnings and revenue surprises of 1.60% and 35.72%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | May 2, 2023

Sage Therapeutics Announces First Quarter 2023 Financial Results and Highlights Pipeline and Business Progress

CAMBRIDGE, Mass., May 02, 2023--Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, today reported business highlights and financial results for the first quarter ended March 31, 2023.

Yahoo | May 2, 2023

Earnings Preview: United Therapeutics (UTHR) Q1 Earnings Expected to Decline

United Therapeutics (UTHR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | April 26, 2023

Sage Therapeutics, Inc. (NASDAQ:SAGE) insiders placed bullish bets worth US$752k in the last 12 months

In the last year, multiple insiders have substantially increased their holdings of Sage Therapeutics, Inc...

Yahoo | April 26, 2023

Analysts Estimate Sage Therapeutics, Inc. (SAGE) to Report a Decline in Earnings: What to Look Out for

Sage Therapeutics, Inc. (SAGE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | April 25, 2023

Sage Therapeutics to Report First Quarter 2023 Financial Results on Tuesday, May 2, 2023

CAMBRIDGE, Mass., April 18, 2023--Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that it will host a live webcast on Tuesday, May 2, 2023 at 8:00 a.m. ET to review first quarter 2023 financial results and discuss recent business updates.

Yahoo | April 18, 2023

Sage Therapeutics to Present at the Stifel 2023 CNS Days

CAMBRIDGE, Mass., March 22, 2023--Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that the Company will present at the Stifel 2023 CNS Days on Wednesday, March 29, 2023, at 11:00 a.m. ET.

Yahoo | March 22, 2023

Sage Therapeutics Appoints Jessica Federer to Board of Directors

CAMBRIDGE, Mass., March 16, 2023--Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, today announced the appointment of Jessica Federer to the company’s Board of Directors.

Yahoo | March 16, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6624 seconds.